BusinessARCA biopharma Reports Topline Phase 2B Results for GENETIC-AF Clinical TrialBy Nasdaq OMXFeb 26, 2018, 1:00 PM UTC
BusinessARCA biopharma Announces Completion of GENETIC-AF Phase 2B Clinical TrialBy Nasdaq OMXJan 8, 2018, 1:31 PM UTC
BusinessARCA biopharma Announces Third Quarter 2017 Financial Results and Provides Business UpdateBy Nasdaq OMXNov 9, 2017, 9:05 PM UTC